Abbott Total Other Income Expense Net from 2010 to 2025
| ABT Stock | USD 128.54 0.91 0.71% |
Total Other Income Expense Net | First Reported 1985-09-30 | Previous Quarter 90 M | Current Value 98 M | Quarterly Volatility 667.9 B |
Check Abbott Laboratories financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Abbott Laboratories' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.7 B, Interest Expense of 572.9 M or Selling General Administrative of 6.4 B, as well as many indicators such as Price To Sales Ratio of 4.9, Dividend Yield of 0.0186 or PTB Ratio of 2.63. Abbott financial statements analysis is a perfect complement when working with Abbott Laboratories Valuation or Volatility modules.
Abbott | Total Other Income Expense Net | Build AI portfolio with Abbott Stock |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Abbott Stock Analysis
When running Abbott Laboratories' price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.